COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY

被引：1
|
作者：
Toumi, M. [1 ]
Lamure, M. [1 ]
Grishchenko, M. [2 ]
Cochran, J. [2 ]
Rive, B. [1 ]
机构：
[1] Univ Lyon 1, F-69622 Villeurbanne, France
[2] Lundbeck SAS, Paris, France
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74819-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A370 / A370
页数：1
相关论文
共 50 条
  • [21] Memantine (Namenda) for moderate to severe Alzheimer's disease
    Ables, AZ
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (06) : 1491 - 1492
  • [22] Memantine in moderate-to-severe Alzheimer's disease
    Bleich, S
    Wiltfang, J
    Kornhuber, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 609 - 610
  • [23] Spotlight on Memantine in Moderate to Severe Alzheimer's Disease
    McKeage, Kate
    DRUGS & AGING, 2010, 27 (02) : 177 - 179
  • [24] The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease
    Loveman, E
    Green, C
    Kirby, J
    Takeda, A
    Picot, J
    Payne, E
    Clegg, A
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (01) : III - +
  • [25] Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
    Anders Wimo
    Bengt Winblad
    Albrecht Stöffler
    Yvonne Wirth
    Hans-Jörg Möbius
    PharmacoEconomics, 2003, 21 : 327 - 340
  • [26] Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer’s Disease
    T. Heinen-Kammerer
    H. Rulhoff
    S. Nelles
    R. Rychlik
    Clinical Drug Investigation, 2006, 26 : 303 - 314
  • [27] Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease
    Heinen-Kammerer, T.
    Rulhoff, H.
    Nelles, S.
    Rychlik, R.
    CLINICAL DRUG INVESTIGATION, 2006, 26 (06) : 303 - 314
  • [28] Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
    Wimo, A
    Winblad, B
    Stoffler, A
    Wirth, Y
    Möbius, HJ
    PHARMACOECONOMICS, 2003, 21 (05) : 327 - 340
  • [29] Positive effects of memantine treatment in patients with moderate to severe Alzheimer's disease
    Gauthier, S
    Wirth, Y
    Moebius, HJ
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 206 - 206
  • [30] Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Möbius, HJ
    NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
12345